Tongling Jieya Biologic Technology Co Ltd
SZSE:301108
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
21.25
36.68
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Tongling Jieya Biologic Technology Co Ltd
Capital Expenditures
Tongling Jieya Biologic Technology Co Ltd
Capital Expenditures Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Capital Expenditures | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
T
|
Tongling Jieya Biologic Technology Co Ltd
SZSE:301108
|
Capital Expenditures
-¥85.1m
|
CAGR 3-Years
6%
|
CAGR 5-Years
-55%
|
CAGR 10-Years
N/A
|
|
|
Hengan International Group Company Ltd
HKEX:1044
|
Capital Expenditures
-¥1.5B
|
CAGR 3-Years
-25%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
-4%
|
|
|
Proya Cosmetics Co Ltd
SSE:603605
|
Capital Expenditures
-¥186.2m
|
CAGR 3-Years
13%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
|
Yunnan Botanee Bio-Technology Group Co Ltd
SZSE:300957
|
Capital Expenditures
-¥274.3m
|
CAGR 3-Years
-45%
|
CAGR 5-Years
-54%
|
CAGR 10-Years
N/A
|
|
|
By-health Co Ltd
SZSE:300146
|
Capital Expenditures
-¥1.3B
|
CAGR 3-Years
-58%
|
CAGR 5-Years
-38%
|
CAGR 10-Years
N/A
|
|
|
G
|
Giant Biogene Holding Co Ltd
HKEX:2367
|
Capital Expenditures
-¥228.4m
|
CAGR 3-Years
65%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Tongling Jieya Biologic Technology Co Ltd
Glance View
Tongling Jieya Biologic Technology Co., Ltd. engages in the research and development, production, and sale of wet wipes. The company is headquartered in Tongling, Anhui and currently employs 798 full-time employees. The company went IPO on 2021-12-03. The firm's main businesses are the research and development, production and sales of sanitary products. The firm's wet wipes products include baby series, adult functional series, antibacterial disinfection series, household cleaning series, medical care series and pet cleaning series. The firm is also engaged in the production of facial masks.
See Also
What is Tongling Jieya Biologic Technology Co Ltd's Capital Expenditures?
Capital Expenditures
-85.1m
CNY
Based on the financial report for Dec 31, 2023, Tongling Jieya Biologic Technology Co Ltd's Capital Expenditures amounts to -85.1m CNY.
What is Tongling Jieya Biologic Technology Co Ltd's Capital Expenditures growth rate?
Capital Expenditures CAGR 5Y
-55%
Over the last year, the Capital Expenditures growth was -184%. The average annual Capital Expenditures growth rates for Tongling Jieya Biologic Technology Co Ltd have been 6% over the past three years , -55% over the past five years .
You don't have any saved screeners yet
